TheProfitWatch

QURE - uniQure N.V.

Day 1m 10m 60m PreMarket Market AfterHours Gap
58.95 3.55 (6.02%) --- 0.0 (0.0%) -0.5 (-0.79%) 0.32 (0.54%) 3.88 (6.58%) -0.08 (-0.13%) -0.08 (-0.13%)

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.69
Diluted EPS:
-0.69
Basic P/E:
-90.5797
Diluted P/E:
-90.5797
RSI(14) 1m:
0.0
VWAP:
62.5
RVol:
0.2803

Events

Period Kind Movement Occurred At
1m Price increase 1m 60.28 +0.62 (+1.03%) Oct 15 09:42
1m Price increase 1m 61.0 +1.09 (+1.82%) Oct 15 08:57

Related News